We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bayer, CRISPR Therapeutics Establish JV

News   Aug 26, 2016

 
Bayer, CRISPR Therapeutics Establish JV
 
 
 

RELATED ARTICLES

A Highly Precise Cas9 Enzyme, SaCas9-HF, Is Added to the CRISPR Toolbox

News

A team of scientists from City University of Hong Kong (CityU) and the Karolinska Institute has created a novel protein that can increase the target accuracy in genome editing.

READ MORE

Sleeping Beauty Awakens to a Makeover and a Job in Genome Engineering

News

In a new study, scientists from the European Molecular Biology Laboratory, the Universitätsklinikum Würzburg and the Paul-Ehrlich-Institut have designed a novel variant of the Sleeping Beauty transposase, enabling its direct use for genome modifications.

READ MORE

Developing New Delivery Tools for Gene Editing

News

Scientists led by University of Iowa researcher Paul McCray, Jr., MD, are using simple peptides to deliver gene-editing tools into notoriously hard-to-access lung and airway cells with the goal of creating new treatments for people with diseases like cystic fibrosis, COPD, and asthma.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE